Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-14 Ray Amrit Director Grant or award +7,751 31,116
2026-05-14 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +14,058 14,058
2025-05-15 Ray Amrit Director Grant or award +5,740 23,365
2025-05-15 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +10,787 10,787
2024-06-18 Ray Amrit Director Grant or award +5,345 17,625
2024-06-18 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +9,900 9,900
2023-06-07 Ray Amrit Director Grant or award +3,860 12,280
2023-06-07 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2022-06-24 Ray Amrit Director Grant or award +3,300 8,420
2022-06-24 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +6,245 6,245
2022-04-19 Ray Amrit Director Grant or award +5,120 5,120
2022-04-19 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +9,525 9,525

Page 1 of 1 · 12 trades